Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia (CML): reports collected by the French regional pharmacovigilance (PV) centers

Markarian M.; Carlier P.; Bernard N.; Lagarce L.; Dautriche A.; Bene J.; Eftekhari P.

首页> 外文期刊>Fundamental & clinical pharmacology. >Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia (CML): reports collected by the French regional pharmacovigilance (PV) centers

【24h】

Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia (CML): reports collected by the French regional pharmacovigilance (PV) centers

机译：在慢性髓性白血病（CML）中接受伊马替尼，达斯替尼或尼洛尼菌属的男性患者的伴侣孕孕：由法国区域药物检药（PV）中心收集的报告

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Fundamental & clinical pharmacology.》 |2016年第1期|共1页
作者
Markarian M.; Carlier P.; Bernard N.; Lagarce L.; Dautriche A.; Bene J.; Eftekhari P.;
展开▼
作者单位

Hop Fernand Widal AP HP Ctr Reg Pharmacovigilance Paris France;

Hop Fernand Widal AP HP Ctr Reg Pharmacovigilance Paris France;

Hosp Civils Lyon Ctr Reg Pharmacovigilance Lyon France;

CHRU Angers Ctr Reg Pharmacovigilance Angers France;

CHU Dijon Ctr Reg Pharmacovigilance Dijon France;

CHRU Lille Ctr Reg Pharmacovigilance F-59037 Lille France;

Hop Fernand Widal AP HP Ctr Reg Pharmacovigilance Paris France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
入库时间 2022-08-20 03:44:13

相似文献

外文文献
中文文献
专利

1. Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia (CML): reports collected by the French regional pharmacovigilance (PV) centers [J] . Markarian M., Carlier P., Bernard N., Fundamental & clinical pharmacology. . 2016,第Suppla1期

机译：在慢性髓性白血病（CML）中接受伊马替尼，达斯替尼或尼洛尼菌属的男性患者的伴侣孕孕：由法国区域药物检药（PV）中心收集的报告
2. Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib? Evaluation of Saglio G, Kim D-W, Issaragrisil S, et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 2010;362:2251-9, and Kantarjian H, Shah NP, Hochhaus A, et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2010;362:2260-70. [J] . Doggrell SA, Christensen AM Expert opinion on pharmacotherapy . 2011,第1期

机译：是否有比伊马替尼更好的Bcr-Abl激酶抑制剂用于慢性粒细胞白血病？ Saglio G，Kim D-W，Issaragrisil S等的评估。尼洛替尼与伊马替尼治疗新诊断的慢性粒细胞白血病。 N Engl J Med 2010; 362：2251-9，and Kantarjian H，Shah NP，Hochhaus A等。达沙替尼与伊马替尼治疗新近诊断的慢性期慢性粒细胞白血病。 N Engl J Med 2010; 362：2260-70。
3. Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib [J] . Naoto Takahashi, Masatomo Miura, Jun Kuroki, Biomarker Research . 2014,第1期

机译：尼洛替尼治疗伊马替尼耐药或不耐受的慢性粒细胞白血病的多中心II期临床试验，来自日本东部CML研究组，评估了其分子响应以及尼洛替尼的疗效和安全性
4. Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or -intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib [O] . Naoto Takahashi, Masatomo Miura, Jun Kuroki, 2014

机译：尼洛替尼用于伊马替尼耐药或不耐受的慢性粒细胞白血病的多中心II期临床试验来自日本东部CML研究组评估其分子反应以及尼洛替尼的疗效和安全性
5. Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers [O] . Patrick Carlier, Maritza Markarian, Nathalie Bernard, 2017

机译：错误：在慢性骨髓白血病中接受伊马替尼，达斯替尼或尼洛尼的男性患者的伴侣怀孕结果：法国网络药理治中心收集的报告

Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia (CML): reports collected by the French regional pharmacovigilance (PV) centers

著录项

相似文献

相关主题

期刊订阅